A COMPARISON OF ANTI-INFLAMMATORY EFFECT OF ONCE-DAILY FLUTICASONE FUROATE/VILANTEROL 200/25 WITH TWICE-DAILY FLUTICASONE PROPIONATE/SALMETEROL 500/50 IN MODERATE TO SEVERE ASTHMATICS

Hojo Masayuki; Hirashima Junko; Iikura Motoyasu; Sugiyama Haruhito

首页> 外文期刊>Respirology : >A COMPARISON OF ANTI-INFLAMMATORY EFFECT OF ONCE-DAILY FLUTICASONE FUROATE/VILANTEROL 200/25 WITH TWICE-DAILY FLUTICASONE PROPIONATE/SALMETEROL 500/50 IN MODERATE TO SEVERE ASTHMATICS

【24h】

A COMPARISON OF ANTI-INFLAMMATORY EFFECT OF ONCE-DAILY FLUTICASONE FUROATE/VILANTEROL 200/25 WITH TWICE-DAILY FLUTICASONE PROPIONATE/SALMETEROL 500/50 IN MODERATE TO SEVERE ASTHMATICS

机译：一次至两次重度氟替卡松丙酸酯/沙美特罗/ 500/50氟替卡松/氟那西松200/25的抗炎作用比较

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Respirology :》 |2015年第3期|共1页
作者
Hojo Masayuki; Hirashima Junko; Iikura Motoyasu; Sugiyama Haruhito;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类呼吸系及胸部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. A COMPARISON OF ANTI-INFLAMMATORY EFFECT OF ONCE-DAILY FLUTICASONE FUROATE/VILANTEROL 200/25 WITH TWICE-DAILY FLUTICASONE PROPIONATE/SALMETEROL 500/50 IN MODERATE TO SEVERE ASTHMATICS [J] . Hojo Masayuki, Hirashima Junko, Iikura Motoyasu, Respirology : . 2015,第Suppla3期

机译：一次至两次重度氟替卡松丙酸酯/沙美特罗/ 500/50氟替卡松/氟那西松200/25的抗炎作用比较
2. A comparison of the efficacy and safety of once-daily fluticasone furoate/vilanterol with twice-daily fluticasone propionate/salmeterol in moderate to very severe COPD [J] . Alvar Agustí, Courtney Crim, Jean Bourbeau, The European respiratory journal : . 2014,第3期

机译：每日两次糠酸氟替卡松/维兰特罗与每日两次丙酸氟替卡松/沙美特罗治疗中度至重度COPD的疗效和安全性比较
3. Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients [J] . DransfieldM.T., FeldmanG., KorenblatP., Respiratory medicine . 2014,第8期

机译：每日一次糠酸氟替卡松/维兰特罗（100/25 mcg）与每日两次丙酸氟替卡松/沙美特罗（250/50 mcg）的疗效和安全性
4. Comparison of the cost -effectiveness of triamcinolone acetonide (Azmacort HFA) and fluticasone propionate (Flovent) in adult asthmatics in a randomized controlled equivalence trial [D] . Lee, Todd Allen 2001

机译：在一项随机对照试验中比较曲安奈德（Azmacort HFA）和丙酸氟替卡松（Flovent）在成年哮喘患者中的成本-效果比较
5. Efficacy and Safety of Fluticasone Furoate/Vilanterol Compared With Fluticasone Propionate/Salmeterol Combination in Adult and Adolescent Patients With Persistent Asthma [O] . Ashley Woodcock, Eugene R. Bleecker, Jan Lötvall, -1

机译：氟替卡松富尿酸/紫杉醇与丙酸氟替卡松/沙美特罗联合治疗成人和青少年持续性哮喘的疗效和安全性
6. Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients [O] . Dransfield Mark T., Feldman Gregory, Korenblat Phillip, 2014

机译：每天一次糠酸氟替卡松/维兰特罗（100 / 25mcg）与每日两次丙酸氟替卡松/沙美特罗（250 / 50mcg）的疗效和安全性

A COMPARISON OF ANTI-INFLAMMATORY EFFECT OF ONCE-DAILY FLUTICASONE FUROATE/VILANTEROL 200/25 WITH TWICE-DAILY FLUTICASONE PROPIONATE/SALMETEROL 500/50 IN MODERATE TO SEVERE ASTHMATICS

著录项

引文网络

相似文献

相关主题

期刊订阅